2024年4月15日 · Regaining the top spot on the 2023 list is Johnson & Johnson, which had a sales increase of 6.5% to $85.2 billion. It’s a familiar perch for J&J, which had a decade-long run from 2012 to 2021...

The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year.

2023年4月18日 · Behind Pfizer, companies such as J&J, Roche, Merck and AbbVie made the list of the largest drugmakers by revenue in 2022. Questex. For the first time in biopharma history, a company has topped...

List of the largest pharma companies by market capitalization. Only the top publicly traded pharma companies are shown in this list. A pharmaceutical company is a company that is involved in the research, development or distribution of drugs and medication.

2025年1月12日 · The pharmaceutical industry in 2024 has been incredibly dynamic, showcasing remarkable growth for some companies while presenting challenges for others. It’s the perfect time to reflect on the year’s performance and take a closer look at the Top 20 pharmaceutical companies by market value.

2024年12月7日 · Top 20 Global Pharma Companies (2023) US pharmaceutical companies dominate the list of the top 20 global pharmaceutical companies, with 9 out of the 20 companies, followed by Germany (3), Switzerland (2), UK (2), France …

2024年9月23日 · Here enlisted The Global Top 20 Pharmaceutical Companies. 1. Johnson & Johnson reclaimed the top spot in 2024. The company has a diversified portfolio with strong revenue growth from key treatments like Darzalex, a monoclonal antibody that saw a …

2024年11月17日 · While Merck ($63.9B) and Pfizer ($62.5B) hold the top spots, double-digit growth from AstraZeneca (~18%), Eli Lilly (~34%), Novo Nordisk (~26%), and Amgen (~18%) signals an accelerating transformation in the sector’s competitive landscape.

2024年4月11日 · With a CAGR of 7.8 %, the global biopharma industry is anticipated to register a market size of $799.76B by 2030. In 2023, JNJ ranked first in our list with a total reported revenue of $85.16B followed by Roche and Merck & Co. With $69.78B and $60.11B respectively. 20. Boehringer Ingelheim.

2024年4月26日 · Fierce Pharma publishes a yearly special report highlighting the top 20 pharmas based on their revenue. The most recent edition, published this month, ranks each pharma …